Concepedia

David J. Cowan

DJ

Statistics

Publications

13

Citations

1.2K

H-Index

12

Active since

1995

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

David J. Cowan is an author at Research Triangle Park Foundation specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

1995–2017

13

Publications

13

The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of Thiazolidinediones

Timothy M. Willson, Jeffery E. Cobb, David J. Cowan et al. · Journal of Medicinal Chemistry · 1996 · 639 citations · Full text

, , +9

Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors

Curt D. Haffner, J. David Becherer, Eric E. Boros et al. · Journal of Medicinal Chemistry · 2015 · 136 citations · Full text

, , +13

Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes

Yulin Wu, Christopher Aquino, David J. Cowan et al. · Journal of Medicinal Chemistry · 2013 · 79 citations · Full text

, , +13

Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE)

Michael H. Rabinowitz, Robert Andrews, J. David Becherer et al. · Journal of Medicinal Chemistry · 2001 · 73 citations · Full text

, , +17

Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38

J. David Becherer, Eric E. Boros, Tiffany Carpenter et al. · Journal of Medicinal Chemistry · 2015 · 56 citations · Full text

, , +12

1–5 of 13